Zacks Investment ResearchThu, 07 May 2026 13:51:16 GMTRapport Therapeutics, Inc. (RAPP) Reports Q1 LossRAPP+2.26%
Zacks Investment ResearchThu, 26 Mar 2026 17:00:37 GMTAll You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to BuyRAPP+2.26%
Seeking AlphaTue, 17 Mar 2026 19:32:18 GMTRapport Therapeutics, Inc. (RAPP) Presents at Stifel 2026 Virtual CNS Forum TranscriptRAPP+2.26%